Impact of claudin 18.2 expression on the efficacy of trastuzumab deruxtecan in patients with HER2-positive gastric or gastroesophageal junction cancer
Claudin 18.2 表达对 HER2 阳性胃癌或胃食管交界处癌患者曲妥珠单抗疗效的影响
期刊:
影响因子:
doi:10.1016/j.esmogo.2025.100300
Okemoto, D; Nakayama, I; Jubashi, A; Sakamoto, N; Okunaka, M; Matsubara, Y; Miyashita, Y; Kobayashi, A; Okazaki, U; Yamamoto, K; Seguchi, K; Hosokai, T; Ogura, T; Mishima, S; Kotani, D; Kawazoe, A; Hashimoto, T; Kuboki, Y; Bando, H; Kojima, T; Yoshino, T; Kuwata, T; Yamaguchi, T; Nishikawa, H; Shitara, K